Literature DB >> 15454656

Six month radiological and physiological outcomes in severe acute respiratory syndrome (SARS) survivors.

C K Ng1, J W M Chan, T L Kwan, T S To, Y H Chan, F Y Y Ng, T Y W Mok.   

Abstract

BACKGROUND: The long term physiological and radiological outcomes of SARS survivors and their possible determinants are uncertain.
METHODS: SARS survivors in a follow up clinic in a regional hospital underwent high resolution computed tomography (HRCT) of the thorax and lung function tests 6 months after admission to hospital. The associations between the clinical and demographic data of the patients and the physiological and radiological outcomes were examined.
RESULTS: Fifty seven patients took part in the study. Lung function abnormalities were detected in 43 patients (75.4%), with restrictive defects (n = 16) being most common (28.1%). Radiological abnormalities of any degree were detected in 43 patients (75.4%). Only the use of pulse corticosteroids was associated with the presence of CT abnormalities (p = 0.043, OR 6.65, 95% CI 1.06 to 41.73).
CONCLUSIONS: Physiological and radiological abnormalities are still present in a considerable proportion of SARS survivors at 6 months.

Entities:  

Mesh:

Year:  2004        PMID: 15454656      PMCID: PMC1746851          DOI: 10.1136/thx.2004.023762

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  9 in total

1.  Changes in lung parenchyma after acute respiratory distress syndrome (ARDS): assessment with high-resolution computed tomography.

Authors:  I M Nöbauer-Huhmann; K Eibenberger; C Schaefer-Prokop; H Steltzer; W Schlick; K Strasser; P Fridrich; C J Herold
Journal:  Eur Radiol       Date:  2001-09-15       Impact factor: 5.315

2.  Severe acute respiratory syndrome (SARS): imaging findings during the acute and recovery phases of disease.

Authors:  Jeffrey Seow-Kuang Goh; Ian Yu-Yan Tsou; Gregory Jon-Leng Kaw
Journal:  J Thorac Imaging       Date:  2003-07       Impact factor: 3.000

3.  A follow-up study of 69 discharged SARS patients.

Authors:  Yun Han; Hui Geng; Weibin Feng; Xiangjiang Tang; Aihua Ou; Yingrong Lao; Yinji Xu; Hao Lin; Hui Liu; Yongwen Li
Journal:  J Tradit Chin Med       Date:  2003-09       Impact factor: 0.848

4.  Long-term assessment of lung function in survivors of severe ARDS.

Authors:  Thomas A Neff; Reto Stocker; Hans-Rudolf Frey; Sonja Stein; Erich W Russi
Journal:  Chest       Date:  2003-03       Impact factor: 9.410

5.  One-year outcomes in survivors of the acute respiratory distress syndrome.

Authors:  Margaret S Herridge; Angela M Cheung; Catherine M Tansey; Andrea Matte-Martyn; Natalia Diaz-Granados; Fatma Al-Saidi; Andrew B Cooper; Cameron B Guest; C David Mazer; Sangeeta Mehta; Thomas E Stewart; Aiala Barr; Deborah Cook; Arthur S Slutsky
Journal:  N Engl J Med       Date:  2003-02-20       Impact factor: 91.245

6.  Thin-section CT of severe acute respiratory syndrome: evaluation of 73 patients exposed to or with the disease.

Authors:  K T Wong; Gregory E Antonio; David S C Hui; Nelson Lee; Edmund H Y Yuen; Alan Wu; C B Leung; T H Rainer; Peter Cameron; Sydney S C Chung; Joseph J Y Sung; Anil T Ahuja
Journal:  Radiology       Date:  2003-05-08       Impact factor: 11.105

7.  Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS).

Authors:  J W M Chan; C K Ng; Y H Chan; T Y W Mok; S Lee; S Y Y Chu; W L Law; M P Lee; P C K Li
Journal:  Thorax       Date:  2003-08       Impact factor: 9.139

8.  Thin-section CT in patients with severe acute respiratory syndrome following hospital discharge: preliminary experience.

Authors:  Gregory E Antonio; K T Wong; David S C Hui; Alan Wu; Nelson Lee; Edmund H Y Yuen; C B Leung; T H Rainer; Peter Cameron; Sydney S C Chung; Joseph J Y Sung; Anil T Ahuja
Journal:  Radiology       Date:  2003-06-12       Impact factor: 11.105

Review 9.  SARS: prognosis, outcome and sequelae.

Authors:  K S Chan; J P Zheng; Y W Mok; Y M Li; Y N Liu; C M Chu; M S Ip
Journal:  Respirology       Date:  2003-11       Impact factor: 6.424

  9 in total
  43 in total

1.  Impact of severe acute respiratory syndrome (SARS) on pulmonary function, functional capacity and quality of life in a cohort of survivors.

Authors:  D S Hui; G M Joynt; K T Wong; C D Gomersall; T S Li; G Antonio; F W Ko; M C Chan; D P Chan; M W Tong; T H Rainer; A T Ahuja; C S Cockram; J J Y Sung
Journal:  Thorax       Date:  2005-05       Impact factor: 9.139

2.  Investigating phenotypes of pulmonary COVID-19 recovery: A longitudinal observational prospective multicenter trial.

Authors:  Thomas Sonnweber; Piotr Tymoszuk; Sabina Sahanic; Anna Boehm; Alex Pizzini; Anna Luger; Christoph Schwabl; Manfred Nairz; Philipp Grubwieser; Katharina Kurz; Sabine Koppelstätter; Magdalena Aichner; Bernhard Puchner; Alexander Egger; Gregor Hoermann; Ewald Wöll; Günter Weiss; Gerlig Widmann; Ivan Tancevski; Judith Löffler-Ragg
Journal:  Elife       Date:  2022-02-08       Impact factor: 8.140

3.  A prospective cohort study on radiological and physiological outcomes of recovered COVID-19 patients 6 months after discharge.

Authors:  Mengqi Liu; Fajin Lv; Yineng Zheng; Kaihu Xiao
Journal:  Quant Imaging Med Surg       Date:  2021-09

4.  Quality of life (QoL) among COVID-19 recovered healthcare workers in Bangladesh.

Authors:  Md Utba Rashid; Md Abdullah Saeed Khan; Koustuv Dalal; Soumik Kha Sagar; Mosharop Hossian; Sabrina Yesmin Barsha; Miah Md Akiful Haque; Mohammad Ali Hossain; Mohammad Hayatun Nabi; Mohammad Delwer Hossain Hawlader
Journal:  BMC Health Serv Res       Date:  2022-05-30       Impact factor: 2.908

Review 5.  Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection.

Authors:  Vincent C C Cheng; Susanna K P Lau; Patrick C Y Woo; Kwok Yung Yuen
Journal:  Clin Microbiol Rev       Date:  2007-10       Impact factor: 26.132

6.  Medium-Term Outcomes in Severely to Critically Ill Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.

Authors:  Nandan Gautam; Shyam Madathil; Natascia Tahani; Shaun Bolton; Dhruv Parekh; James Stockley; Shraddha Goyal; Hannah Qureshi; Sadhika Yasmin; Brendan G Cooper; Jennifer Short; Tarekegn Geberhiwot
Journal:  Clin Infect Dis       Date:  2022-01-29       Impact factor: 9.079

7.  Persistence of lung inflammation and lung cytokines with high-resolution CT abnormalities during recovery from SARS.

Authors:  Chun-Hua Wang; Chien-Ying Liu; Yung-Liang Wan; Chun-Liang Chou; Kuo-Hsiung Huang; Horng-Chyuan Lin; Shu-Min Lin; Tzou-Yien Lin; Kian Fan Chung; Han-Pin Kuo
Journal:  Respir Res       Date:  2005-05-11

8.  Mesenchymal Stromal Cell Secretome for Post-COVID-19 Pulmonary Fibrosis: A New Therapy to Treat the Long-Term Lung Sequelae?

Authors:  Elia Bari; Ilaria Ferrarotti; Laura Saracino; Sara Perteghella; Maria Luisa Torre; Luca Richeldi; Angelo Guido Corsico
Journal:  Cells       Date:  2021-05-14       Impact factor: 6.600

Review 9.  Changes in the respiratory function of COVID-19 survivors during follow-up: A novel respiratory disorder on the rise?

Authors:  Afroditi K Boutou; Athina Georgopoulou; Georgia Pitsiou; Ioannis Stanopoulos; Theodoros Kontakiotis; Ioannis Kioumis
Journal:  Int J Clin Pract       Date:  2021-05-17       Impact factor: 3.149

10.  Pulmonary sequelae of moderate-to-severe COVID pneumonia, a 3-month follow-up study.

Authors:  Sumeet Vimal Kishor Singhania; Caroline Simon; Abhijit Raut; Nikhil Parvatkar
Journal:  Lung India       Date:  2021 Jul-Aug
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.